Recent Price Movement and Market Context
On 28 Nov 2025, Entero Healthcare Solutions recorded its lowest price in the past year at Rs.1023.2. This level contrasts sharply with its 52-week high of Rs.1564.95, indicating a substantial gap of approximately 34.6%. Over the last four trading sessions, the stock has consistently moved downward, underperforming its sector by 0.53% on the day of the new low.
Despite this, the broader market environment remains positive. The Sensex opened flat but gained 0.12% to trade at 85,822.49, just 0.27% shy of its own 52-week high of 86,055.86. The index is supported by bullish moving averages, with the 50-day moving average positioned above the 200-day moving average, signalling sustained market strength. Mega-cap stocks are leading this upward momentum, contrasting with the performance of Entero Healthcare Solutions.
Technical Indicators Reflect Bearish Trends
Technical analysis of Entero Healthcare Solutions reveals that the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This positioning suggests a prevailing downward trend in the short, medium, and long term. The sustained trading below these averages often indicates a cautious market sentiment towards the stock.
Long-Term Performance Compared to Benchmarks
Over the past year, Entero Healthcare Solutions has generated a return of -23.23%, a stark contrast to the Sensex’s positive return of 8.59% during the same period. This divergence highlights the stock’s relative underperformance within the retailing sector and the broader market. Additionally, the stock has lagged behind the BSE500 index over the last three years, one year, and three months, underscoring a pattern of subdued returns.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Financial Health and Profitability Metrics
Despite the recent price weakness, Entero Healthcare Solutions exhibits several positive financial indicators. The company maintains a low Debt to EBITDA ratio of 1.33 times, reflecting a strong capacity to service its debt obligations. This ratio suggests prudent financial management and a manageable leverage position.
Net sales have shown a compound annual growth rate of 30.10%, while operating profit has expanded at an even more robust annual rate of 127.38%. These figures indicate that the company has been able to grow its top line and improve operational profitability over the long term.
Quarterly results further reinforce this trend, with the company reporting its highest PAT at Rs.31.60 crores, net sales reaching Rs.1,570.95 crores, and PBDIT at Rs.62.06 crores in the most recent quarter. These figures mark seven consecutive quarters of positive results, signalling consistent earnings generation.
Valuation and Return Metrics
Entero Healthcare Solutions holds a Return on Capital Employed (ROCE) of 8.6%, which is considered attractive within its sector. The enterprise value to capital employed ratio stands at 2.3, indicating a valuation level that is lower than the average historical valuations of its peers. This discount in valuation may reflect market caution given the stock’s recent price performance.
Interestingly, while the stock has produced a negative return over the past year, its profits have risen by 142% during the same period. The price-to-earnings-to-growth (PEG) ratio is 0.3, suggesting that earnings growth has outpaced the stock price movement.
Shareholding Pattern
Institutional investors hold 24.32% of Entero Healthcare Solutions’ shares. This level of institutional ownership indicates a significant presence of investors with access to detailed fundamental analysis and resources, which may influence the stock’s trading dynamics.
Holding Entero Healthcare Solutions from Retailing? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Considerations
Entero Healthcare Solutions’ stock price reaching a 52-week low of Rs.1023.2 reflects a period of sustained price pressure despite the company’s solid financial performance and growth metrics. The stock’s position below all major moving averages and its underperformance relative to the Sensex and sector indices highlight the challenges it faces in regaining market favour.
Nevertheless, the company’s consistent quarterly profitability, strong sales growth, manageable debt levels, and attractive valuation metrics provide a comprehensive picture of its current standing. The divergence between profit growth and stock price performance may be a point of interest for market participants analysing the stock’s valuation dynamics.
As the broader market continues to trade near record highs, Entero Healthcare Solutions remains a notable example of a stock experiencing a contrasting trajectory within the retailing sector.
Get 1 year of Weekly Picks FREE when you subscribe to MojoOne. Offer ends soon. Start Saving Now →
